Moderna Inc (MRNA)
120.50
+9.04
(+8.11%)
USD |
NASDAQ |
May 02, 12:11
Moderna Cash and Short Term Investments (Quarterly): 8.604B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 8.604B |
September 30, 2023 | 7.573B |
June 30, 2023 | 8.459B |
March 31, 2023 | 8.923B |
December 31, 2022 | 9.902B |
September 30, 2022 | 8.348B |
June 30, 2022 | 7.897B |
March 31, 2022 | 10.12B |
December 31, 2021 | 10.73B |
September 30, 2021 | 8.906B |
June 30, 2021 | 7.99B |
March 31, 2021 | 7.735B |
Date | Value |
---|---|
December 31, 2020 | 4.608B |
September 30, 2020 | 3.276B |
June 30, 2020 | 2.717B |
March 31, 2020 | 1.218B |
December 31, 2019 | 1.103B |
September 30, 2019 | 1.059B |
June 30, 2019 | 1.070B |
March 31, 2019 | 1.109B |
December 31, 2018 | 1.521B |
September 30, 2018 | 1.072B |
December 31, 2017 | 756.03M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.059B
Minimum
Sep 2019
10.73B
Maximum
Dec 2021
6.328B
Average
7.897B
Median
Jun 2022
Cash and Short Term Investments (Quarterly) Benchmarks
Eli Lilly and Co | 2.586B |
Merck & Co Inc | 7.093B |
Pfizer Inc | 12.69B |
Johnson & Johnson | 26.22B |
Novavax Inc | 568.50M |